Dear Colleagues I would like to draw your attention to the upcoming Protein Structure Determination in Industry (PSDI) conference to be held at The Wellcome Genome Campus, Cambridge, UK (November 12th to 14th).
https://registrations.hg3conferences.co.uk/hg3/frontend/reg/thome.csp?pageID=99659&ef_sel_menu=2010&eventID=257 Confirmed sessions and speakers include: Title Speakers Computing for Protein Structure Determination in Industry (Workshop) Duncan Johnstone (GSK) Michael Saur (Astex Pharmaceuticals) Jan Domanski (CHARM Therapeutics) Shawn Stephens (Hewlett Packard Enterprise) Advances and innovation getting sample onto grids: MS soft-landing, time resolved EM, automated vitrification (Workshop) Shane Chandler (GSK) Stephan Rauschenbach (University of Oxford), Radoslav Enchev,Mathieu Botte (leadXpro) Katerina Naydenova (LMB, Cambridge) PROTACS Alessio Ciulli (University of Dundee) Structure-based design of selective and potent bicyclic peptides (Bicycle®) binders to angiotensin-converting enzyme 2 Bicycle Therapeutics Molecular Glues for DUB Complexes Elton Zeqiraj (University of Leeds) Cheaper & more accessible cryoEM structures Katerina Naydenova (LMB, Cambridge) Fragment-Based Discovery of a Novel, Brain Penetrant, Orally Active HDAC2 Inhibitor Judith Reeks (Astex Pharmaceuticals) Unravelling Isoform Selectivity and Potency: Insights into PI3Kγ Inhibition through Integrated Structural and Mutagenesis Studies Tove Sjögren (AstraZeneca) Structure-based discovery of novel antagonists of the human histamine H4 receptor Gregory Verdon (Sosei Heptares) In silico Design of GPCRs for Structure (GPR65) Robert Cheng (leadXpro) CryoEM eif2b Case Study Fiona Shilliday (AstraZeneca) ERAP Case Study Paul Rowland (GSK) Solving IMPs by CryoEM Maryam Khoshouei (Novartis) Time Resolved EM Radoslav Enchev (The Francis Crick Institute) Recovering Conformational Heterogeneity in cryoEM with Deep Learning Johannes Schwab (LMB, Cambridge) LLMs to help with data curation using ChatGPT Andrew Green (EBI, Cambridge) We look forward to seeing you there! GSK monitors email communications sent to and from GSK in order to protect GSK, our employees, customers, suppliers and business partners, from cyber threats and loss of GSK Information. GSK monitoring is conducted with appropriate confidentiality controls and in accordance with local laws and after appropriate consultation. ________________________________ This e-mail was sent by GlaxoSmithKline Services Unlimited (registered in England and Wales No. 1047315), which is a member of the GlaxoSmithKline group of companies. The registered address of GlaxoSmithKline Services Unlimited is 980 Great West Road, Brentford, Middlesex TW8 9GS. ######################################################################## To unsubscribe from the CCP4BB list, click the following link: https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1 This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list hosted by www.jiscmail.ac.uk, terms & conditions are available at https://www.jiscmail.ac.uk/policyandsecurity/
